Catheter-based treatment of Ilio-femoral deep vein thrombosis-an update on current evidence;Die interventionelle Behandlung der ilio-femoralen tiefen Beinvenenthrombose

Vasa - Journal of Vascular Diseases

Volumn 42, Issue 3, 2013, Pages 161-167

  Fahrni, Jennifer ^a   Peter Engelberger, Rolf ^a   Kucher, Nils ^a   Willenberg, Torsten ^a   Baumgartner, Iris ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Deep vein thrombosis; Iliac vein; Mechanical thrombolysis; Postthrombotic syndrome; Thrombolytic therapy; Venous thrombosis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOT LYSIS; CATHETER; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FOLLOW UP; HUMAN; ILIAC VEIN; MECHANICAL THROMBECTOMY; MORBIDITY; POSTTHROMBOSIS SYNDROME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION; REVIEW; RHEOLYTIC THROMBECTOMY; RISK; STENOSIS; SURGICAL THROMBECTOMY;

ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; FEMORAL VEIN; FIBRINOLYTIC AGENTS; HUMANS; ILIAC VEIN; MECHANICAL THROMBOLYSIS; POSTTHROMBOTIC SYNDROME; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 84877120472     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000264     Document Type: Review

References (35)

1. AbuRahma AF, Perkins SE, Wulu JT, and Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous trans-luminal angioplasty and stenting. Ann Surg 2001; 233: 752-760.
2. Ashrani AA and Heit JA. Incidence and cost burden of post-thrombotic syndrome. J T romb T rombolysis 2009; 28: 465-476.
3. Brandjes D P, Buller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, and ten Cate JW. Randomised trial of ef ect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-762.
4. Comerota AJ. The current role of operative venous thrombectomy in deep vein thrombosis. Semin Vasc Surg 2012; 25: 2-12.
5. Comerota AJ and Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Canadian journal of surgery Journal canadien de chirurgie 1993; 36: 359-364.
6. Comerota AJ, Grewal N, Martinez JT, Chen JT, DiSalle R, Andrews L, Sepanski D, and Assi Z. Post-thrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis. Journal of Vascular Surgery 2012; 55: 768-773.
7. Douketis JD, Crowther MA, Foster GA, and Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med 2001; 110: 515-519.
8. Elsharawy M and Elzayat E. Early results of thrombolysis vs antico-agulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 2002; 24: 209-214.
9. Enden T, Haig Y, Klow NE, Slags-vold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, and Sandset PM. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379: 31-38.
10. Enden T, Klow NE, Sandvik L, Slags-vold CE, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, and Sandset PM. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J T romb Haemost 2009; 7: 1268-1275.
11. Francis C W, Blinc A, Lee S, and Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound in medicine & biology 1995; 21: 419-424.
12. Gonzalez-Fajardo JA, Arreba E, Castrodeza J, Perez JL, Fernandez L, Agundez I, Mateo AM, Carrera S, Gutiérrez V, and Vaquero C. Veno-graphic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis. Journal of vascular surgery: of cial publication, the Society for Vascular Surgery 1999; 30: 283-292.
13. Grewal NK, Martinez JT, Andrews L, and Comerota AJ. Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with postthrombotic morbidity. J Vasc Surg 2010; 51: 1209-1214.
14. Hull RD, Marder VJ, Mah AF, Biel RK, and Brant RF. Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: a systematic review. Am J Med 2005; 118: 456-464.
15. Jaf MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, and Zier-ler BK. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein T rombo-sis, and Chronic T romboembolic Pulmonary Hypertension: A Sci-entif c Statement From the American Heart Association. Circulation 2011; 123: 1788-1830.
16. Kahn SR, Shbaklo H, Lamping DL, Holcrof CA, Shrier I, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, and Ginsberg JS. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J T romb Hae-most 2008; 6: 1105-1112.
17. Kahn SR, Shrier I, Julian JA, Du-cruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, and Ginsberg JS. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149: 698-707.
18. Karthikesalingam A, Young EL, Hinchlif e RJ, Lof us IM, T omp-son MM, and Holt PJ. A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis. Eur J Vasc Endovasc Surg 2011; 41: 554-565.
19. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Gold-haber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, and Kahn SR. Antithrombotic T er-apy for VTE Disease: Antithrom-botic T erapy and Prevention of T rombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 2012; 141: e419S-e494S.
20. Kim HS, Patra A, Paxton BE, Khan J, and Streif MB. Adjunctive percutaneous mechanical thrombec-tomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol 2006; 17: 1099-1104.
21. Lee MS MR, Singh V, Rametta S, Valania G, Platzman Z. Pre-procedural administration of aminophylline does not prevent AngioJet rheolytic thrombectomy-induced bradyarrhythmias. The Journal of invasive cardiology 2005; 17: 19-22.
22. Lin PH, Zhou W, Dardik A, Mussa F, Kougias P, Hedayati N, Naoum JJ, El Sayed H, Peden EK, and Huynh TT. Catheter-direct thrombolysis versus pharmacomechanical thrombec-tomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006; 192: 782-788.
23. Mair DCET, Rosen G, Covin R, Harmon J V, Menser M, Hemolysis during percutaneous mechanical thrombectomy can mimic a hemolytic transfusion reaction. Transfusion 2005; 45: 1291-1294.
24. Meyerovitz MF, Polak J F, and Gold-haber SZ. Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance. Radiology 1992; 184: 345-348.
25. Plate G, Akesson H, Einarsson E, Ohlin P, and Eklof B. Long-term results of venous thrombectomy combined with a temporary arterio-venous f stula. Eur J Vasc Surg 1990; 4: 483-489.
26. Popuri RK and Vedantham S. The role of thrombolysis in the clinical management of deep vein thrombosis. Arterioscler T romb Vasc Biol 2011; 31: 479-484.
27. Prandoni P, Frulla M, Sartor D, Concolato A, and Girolami A. Vein abnormalities and the post-throm-botic syndrome. J T romb Haemost 2005; 3: 401-402.
28. Prandoni P, Lensing AWA, Prins MH, Frulla M, Marchiori A, Ber-nardi E, Tormene D, Mosena L, Pag-nan A, and Girolami A. Below-Knee Elastic Compression Stockings To Prevent the Post-T rombotic Syn-dromeA Randomized, Controlled Trial. Annals of Internal Medicine 2004; 141: 249-256.
29. Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, Scannapieco G, Ambrosio GB, Pesavento R, Cuppini S, Quintavalla R, and Agnelli G. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med 2009; 150: 577-585.
30. Raju S and Fredericks R. Venous obstruction: an analysis of one hundred thirty-seven cases with hemo-dynamic, venographic, and clinical correlations. J Vasc Surg 1991; 14: 305-313.
31. Sharif M, Bay C, Mehdipour M, and Sharif J. Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion (TORPEDO) Trial: Midterm Results. Journal of Endovas-cular T erapy 2012; 19: 273-280.
32. Sharif M, Mehdipour M, Bay C, Smith G, and Sharif J. Endo-venous therapy for deep venous thrombosis: the TORPEDO trial. Catheter Cardiovasc Interv 2010; 76: 316-325.
33. Spencer FA, Emery C, Jofe S W, Pacifco L, Lessard D, Reed G, Gore JM, and Goldberg RJ. Incidence rates, clinical prof le, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis 2009; 28: 401-409.
34. Vedantham S, Torpe PE, Cardella JF, Grassi CJ, Patel NH, Ferral H, Hofmann LV, Janne d'Othee BM, Antonaci V P, Brountzos EN, Brown DB, Martin LG, Matsumoto AH, Meranze SG, Miller DL, Millward SF, Min RJ, Neithamer CD, Ra-jan DK, Rholl KS, Schwartzberg MS, Swan TL, Towbin RB, Wiechmann BN, and Sacks D. Quality improvement guidelines for the treatment of lower ex tremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2006; 17: 435-447.
35. Watson LI and Armon MP. Throm-bolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2004: CD002783.